Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.7B |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$593M |
| 3 |
Meta Platforms (Facebook)
META
|
+$508M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$460M |
| 5 |
Netflix
NFLX
|
+$323M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$478M |
| 2 |
RTN
Raytheon Company
RTN
|
+$318M |
| 3 |
Merck
MRK
|
+$257M |
| 4 |
Johnson & Johnson
JNJ
|
+$251M |
| 5 |
Qualcomm
QCOM
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.89% |
| 2 | Healthcare | 14.18% |
| 3 | Financials | 11.46% |
| 4 | Consumer Discretionary | 10.84% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2876
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
| $1.38M | ﹤0.01% |
24,728
+4,594
| +23% | +$252K |
|
2877
AB InBev
BUD
$156B
| $1.37M | ﹤0.01% |
27,840
-664
| -2% | -$31K |
|
2878
Accel Entertainment
ACEL
$1.01B
| $1.37M | ﹤0.01% |
+142,221
| New | +$1.3M |
|
2879
Nice
NICE
$6.03B
| $1.37M | ﹤0.01% |
7,222
-231
| -3% | -$40.5K |
|
2880
Precision BioSciences
DTIL
$203M
| $1.36M | ﹤0.01% |
5,465
+2,143
| +65% | +$469K |
|
2881
State Street SPDR Portfolio S&P 500 Growth ETF
SPYG
$55.3B
| $1.36M | ﹤0.01% |
30,372
-930
| -3% | -$38.6K |
|
2882
National Bankshares
NKSH
$270M
| $1.36M | ﹤0.01% |
47,638
-2,728
| -5% | -$79.4K |
|
|
DX
2883
Dynex Capital
DX
$3.24B
| $1.35M | ﹤0.01% |
94,585
-3,842
| -4% | -$51.4K |
|
2884
Honda
HMC
$40.7B
| $1.35M | ﹤0.01% |
52,859
+3,550
| +7% | +$86.3K |
|
|
ROCC
2885
DELISTED
Ranger Oil Corporation Class A Common Stock
ROCC
| $1.35M | ﹤0.01% |
141,626
-8,368
| -6% | -$64.7K |
|
2886
Fidelity D&D Bancorp
FDBC
$317M
| $1.35M | ﹤0.01% |
28,047
+5,585
| +25% | +$224K |
|
|
TGH
2887
DELISTED
Textainer Group Holdings limited
TGH
| $1.34M | ﹤0.01% |
163,961
+2,550
| +2% | +$20.9K |
|
|
SDC
2888
DELISTED
SmileDirectClub, Inc. Class A Common Stock
SDC
| $1.34M | ﹤0.01% |
169,290
+31,419
| +23% | +$213K |
|
2889
Invesco DB US Dollar Index Bullish Fund
UUP
$414M
| $1.33M | ﹤0.01% |
50,621
-3,883
| -7% | -$104K |
|
|
GNTY
2890
DELISTED
Guaranty Bancshares
GNTY
| $1.33M | ﹤0.01% |
56,635
-1,334
| -2% | -$30.1K |
|
|
CAI
2891
DELISTED
CAI International, Inc.
CAI
| $1.33M | ﹤0.01% |
79,895
-7,070
| -8% | -$118K |
|
|
VIA
2892
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $1.32M | ﹤0.01% |
37,411
+3,324
| +10% | +$119K |
|
2893
AMES National
ATLO
$280M
| $1.32M | ﹤0.01% |
66,729
-2,971
| -4% | -$58.1K |
|
2894
Northrim BanCorp
NRIM
$604M
| $1.32M | ﹤0.01% |
209,436
-16,244
| -7% | -$94.3K |
|
|
CALA
2895
DELISTED
Calithera Biosciences, Inc
CALA
| $1.31M | ﹤0.01% |
12,422
+1,674
| +16% | +$199K |
|
2896
Crawford & Co Class A
CRD.A
$629M
| $1.31M | ﹤0.01% |
166,012
+686
| +0.4% | +$4.65K |
|
2897
Home Bancorp
HBCP
$568M
| $1.31M | ﹤0.01% |
48,967
-6,731
| -12% | -$165K |
|
2898
iRadimed
IRMD
$1.1B
| $1.31M | ﹤0.01% |
56,305
+1,236
| +2% | +$26.5K |
|
2899
NextCure
NXTC
$36.5M
| $1.31M | ﹤0.01% |
5,082
+928
| +22% | +$353K |
|
2900
Spyre Therapeutics
SYRE
$9.04B
| $1.3M | ﹤0.01% |
5,629
+1,825
| +48% | +$348K |
|
Similar funds
Bank of New York Mellon's Q2 2020 Portfolio in Review
As of Q2 2020, Bank of New York Mellon held 4,266 positions worth $375B, up 24% from $302B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q2 2020 filing shows 170 new, 1,923 increased, 1,788 reduced and 190 closed positions. Its largest new stake was Otis Worldwide: 5,903,383 shares worth $336M. The largest sale was Allergan plc, an estimated $478M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q2 2020 buy was Otis Worldwide: 5,903,383 shares worth $336M.
- Bank of New York Mellon added most to Amazon in Q2 2020, an estimated $1.7B increase.
- Bank of New York Mellon's biggest Q2 2020 reduction was Merck, cutting an estimated $257M.
- Bank of New York Mellon fully exited Allergan plc in Q2 2020, selling an estimated $478M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $375B portfolio in Q2 2020.
- Bank of New York Mellon opened 170 new positions and closed 190 in Q2 2020.
- Bank of New York Mellon's portfolio value rose 24% quarter-over-quarter to $375B.
Based on Bank of New York Mellon's 13F filing for Q2 2020, filed 12 Aug 2020.